Trials / Suspended
SuspendedNCT02103166
Role of Hyoscine Bromide in Latent and Active Labor
Randomized, Masked, Placebo-controlled Clinical Trial to Evaluate the Effects of a Single Intravenous Dose of Hyoscine Bromide on the Duration and Pain in Latent and Active Labor
- Status
- Suspended
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- Hospital Clinic of Barcelona · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether hyoscine bromide decreases the duration of the active phase of labor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hyoscine bromide | 20 mg of hyosine bromide diluted in 100 ml of physiological serum (0.9% NaCl). |
| DRUG | Physiological serum | 100 ml of physiological serum (0.9% NaCl). |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2018-04-01
- Completion
- 2018-04-01
- First posted
- 2014-04-03
- Last updated
- 2016-08-19
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02103166. Inclusion in this directory is not an endorsement.